TG Therapeutics TGTX Purchases of equity securities
Purchases of equity securities at other companies
Other financials
Where this comes from
Reported directly by TG Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquireEquitySecuritiesFvNi.
The official record: TG Therapeutics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about TG Therapeutics's purchases of equity securities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is TG Therapeutics's purchases of equity securities?
- TG Therapeutics (TGTX) reported purchases of equity securities of -$0 in Q1 2026.
- How has TG Therapeutics's purchases of equity securities changed year-over-year?
- TG Therapeutics's purchases of equity securities decreased by 100.0% year-over-year, from $1.25M to -$0.
- What does purchases of equity securities mean?
- Cash spent to buy shares or equity stakes in other entities.
- How do you interpret purchases of equity securities?
- Higher outflows suggest a strategy of investing in external growth or equity markets.
- How does purchases of equity securities compare across companies?
- Common for companies with venture arms or significant investment portfolios.